SmartUQ Press Release
MADISON, WI-June 12, 2017: SmartUQ, an uncertainty quantification and analytics software company, announced the addition of Thomas Rockwell Mackie, a highly-regarded medical device expert, as a new adviser.
Dr. Mackie is an Emeritus Professor of the University of Wisconsin - Madison (UW) in the Departments of Medical Physics, Human Oncology and Engineering Physics. At the end of his academic career, he joined the Morgridge Institute as its founding Medical Engineering director where he developed Fab Lab, which pioneered 3D printing and the medical device design program at the UW.
He is a fellow of the American Association of Physicists in Medicine, an honorary member for European Society of Therapeutic Radiology, an author of 180 peer-reviewed publications, and an inventor of 45 issued United States patents.
Beyond his academic success, Dr. Mackie was a founder of the Pinnacle 3D treatment planning system which is now commercialized by Philips Medical and co-founded TomoTherapy which became a public company in 2007 and was sold to Accuray in 2011.
He is also a co-founder of HealthMyne, OnLume and Asto CT, and sits on the board of directors for Shine Medical Technologies, Biolonix and Nano-X.
“We thrilled to have an expert of the medical device industry like Dr. Thomas Mackie as an adviser” said Peter Qian, Chief Scientist at SmartUQ. “He will help guide us, as we continue our mission to find unique solutions to the industry’s challenging analytics problems.”
SmartUQ is a powerful engineering analytics software tool that incorporates real world variability and probabilistic behavior into the analysis of complex systems. The software utilizes breakthrough analytics techniques to rapidly quantify all forms of uncertainties. SmartUQ analtyics tools accelerate design cycles by reducing design iterations, improve design robustness and maximize insight of complex systems by quantifying uncertainties. Learn more here.
SmartUQ Communication and Business Development Specialist